These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 16791898

  • 1. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R, Roberts TL, Stacey KJ, Lenert P.
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [Abstract] [Full Text] [Related]

  • 2. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 3. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R, Lenert P.
    J Immunol; 2005 Feb 15; 174(4):2429-34. PubMed ID: 15699180
    [Abstract] [Full Text] [Related]

  • 4. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.
    Eur J Immunol; 2007 Jul 15; 37(7):1785-95. PubMed ID: 17557373
    [Abstract] [Full Text] [Related]

  • 5. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.
    Eur J Immunol; 2003 Jun 15; 33(6):1633-41. PubMed ID: 12778481
    [Abstract] [Full Text] [Related]

  • 6. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun 15; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 7. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
    Goeken JA, Layer T, Fleenor S, Laccheo M, Lenert P.
    Lupus; 2010 Oct 15; 19(11):1290-301. PubMed ID: 20605877
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, Akira S, Gotoh Y, Kiyono H, Miyake K.
    Int Immunol; 2008 Jul 15; 20(7):881-91. PubMed ID: 18492657
    [Abstract] [Full Text] [Related]

  • 11. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 15; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
    Lindau D, Rönnefarth V, Erbacher A, Rammensee HG, Decker P.
    Eur J Immunol; 2011 Mar 15; 41(3):669-81. PubMed ID: 21287547
    [Abstract] [Full Text] [Related]

  • 14. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K, Hamano T, Kakishita E.
    Ryumachi; 1996 Dec 15; 36(6):844-55. PubMed ID: 9122824
    [Abstract] [Full Text] [Related]

  • 15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 15; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 16. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A, Rothenfusser S, Hornung V, Prell D, Krug A, Kerkmann M, Wellisch D, Poeck H, Greinacher A, Giese T, Endres S, Hartmann G.
    Eur J Immunol; 2005 Aug 15; 35(8):2347-57. PubMed ID: 16025562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan 15; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.